Show simple item record

dc.contributor.authorLavelle, Edward
dc.date.accessioned2021-03-01T18:00:39Z
dc.date.available2021-03-01T18:00:39Z
dc.date.issued2020
dc.date.submitted2020en
dc.identifier.citationLavelle, E.C. and Carsetti, R. and Pickl, W.F. and Wiedermann, U., Editorial: Challenges in Vaccinology, Frontiers in Immunology, 2020, 11, 632537en
dc.identifier.otherY
dc.description.abstractThe COVID19 pandemic has focused minds as rarely before on the vital contribution of vaccines to modern life. In addition to issues related to antigen identification, vaccine adjuvants, vectors and formulations, knowledge is increasing on how a range of factors including age, sex, comorbidities,and the microbiome can impact on responses to vaccines. In this issue, the wide breadth of outstanding issues and opportunities are raised relating to urgent vaccine needs, limitations of current approaches, and the potential of cutting edge technologies to facilitate new advances are highlighted.en
dc.language.isoenen
dc.relation.ispartofseriesFrontiers in Immunology;
dc.relation.ispartofseries11;
dc.relation.ispartofseries632537;
dc.rightsYen
dc.subjectvaccine, systems biology, adjuvant, emerging infectious diseases, nosocomial infections, demographic changes, microbiomeen
dc.subject.lcshvaccine, systems biology, adjuvant, emerging infectious diseases, nosocomial infections, demographic changes, microbiomeen
dc.titleEditorial: Challenges in Vaccinologyen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/lavellee
dc.identifier.rssinternalid224684
dc.identifier.doihttp://dx.doi.org/10.3389/fimmu.2020.632537
dc.rights.ecaccessrightsopenAccess
dc.identifier.orcid_id0000-0002-3167-1080
dc.identifier.urihttp://hdl.handle.net/2262/95452


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record